A registry study of Kawasaki disease patients with coronary artery aneurysms : : 183-8561 2-8-29 Tel. 042-300-5111 FAX. 042-312-8162 E-mail mmiura-pccs@umin.ac.jp : 1.02016630 2.02016925 3.02017831
1. 22231,220111413,00016,00004 10 254305 12.62.8%1.81.9%0.71.0%0.2% Kato et al. 319.2%47.9% 4mm8mm42004 5mm8mm3mm6mm5 4mm6mm6,7 4,5 Z 20172.55.05.010.08 mm10.0 8 mm89,10 Z11.ZSP212Z 10.05.0 13,1415 DOAC1617 11International Kawasaki Disease Symposium201337Z2.5CAA NAKDRThe North American Kawasaki Disease Registry 186211019 119
2. 3. 3.1 120151 2015112020123137.5 2304.0 mmz5.0 3.2 14.0mmZ5.0 2304.0mmZ5.0 3 4 4.1 FAXE 4.2 4.3 1
5. 5.1 5.2 51 N 0 60N15 5.3 6. Ap7 6.1 309030 1 2 Bp11 6.2 N0 60N15 1 2 7. EDCREDCap 8. 8.1 CAA 4 8.2 1 2 3
9. 95%ZSP2 5Z5105%108mm 25%1295%37%1931% CAA 10. 10.1 201791202112312017531 20179120261231 5 10.2 15,000CAA1.01.2% 2/31205600Z200 11. 11.1 2013 20154 11.2 H28b-60 11.3 C: p15 11.4 11.5
12. 12.1 53 12.2 12.3 UMINUMIN 000024768 12.4 AMED COI
A-1 1. 1.1. 309030 9091 90 1 2 CAA AHA #1#2#3#1-2#2-3#5#6#7#11#5-6#6-7 #5-6-11 30 %ASTALTNaCRP a1st line g/kg b 2nd line3rd linea 4th line c ACEi ARB a b
A-2 1.2. 1 0 60 1 2 ACEi ARB,AHA #1#2#3#1-2#2-3#5#6#7#11 #5-6#6-7#5-6-11 30 CTMRA CAA4 6mmZ10525 4.0mmZ50 TIMIGrade03Grade 12AHA #1#2#3#1-2#2-3#5 #6#7#11#5-6#6-7#5-6-1125%50%75% 90%99%100% a b
A-3 2. 2.1. 52065 4 37.5 2.2. 241.1. 2.3. CAA 1 1975AHA report2125%0 25%50%2650%75%5175%90%(7690%)99%9199%100% 2CAA CAA9Haycock Z10CAAZ24,8 3 198322 25%50%75%90%99%100% TIMICAA2Z2 CAAOnouchi et al.231/21/2 b a ab1/223 a bb a 1/2 b a a a1/2b 2.4. CAAAHA 75%CTMRA 100% 2.5. CAA53mm54 mm2430caa
A-4 3. CAA 4 3.1. AHA75% 25,26 ST T 3.2. TCKASTLDH 125-27 STST-TQ 3.3.
B-1 STCsensitivity time control trailing edgeleading edge1 1 2829 Fuse S, Kobayashi T, Arakaki Y, et al. Standard method for ultrasound imaging of coronary artery in children. Pediatr Int. 2010;52:876-882.!http://raise.umin.jp/zsp/download/ZScore-guide.pdf
B-2 3 10-11 Segment 1 View 3 4 Segment 2 3 Segment 2 4 Segment 3
B-3 3 Segment 5 Segment 6 View Segment 6 andor View Segment 7 Segment 11
B-4 a # 2 # 1 b # 3 c # 8 # 7 2 # 6 1 # 5 # 11 a#1#2 b#3 c#5#6#7#8#11 #19.3mm#1-#28.1mm #65.6 mm#78.8 mm
C-1 22017831 KIDCAR 1 2 23% 50% Z 2013
C-2 3 1 20151120201231 1 304.0 mmz5.0 2 309030 11602345 CTMRI 3 4 201791202112311 5 5
C-3 4 1 2 5 6 1 20179202612 2 6001105 7 8 9 UMIN000024768
C-4 10 1 2 5 3 3 11 12 AMED 13
C-5 14 183-8561 2-8-29 Tel.042-300-5111 / / / NTT http://raise.umin.jp/kidcar/ 15.......
C-6..................
C-7..................
13. 1. 183-8561 2-8-29 Tel.042-300-5111 Fax.042-312-8162 E-mailmmiura-pccs@umin.ac.jp 2. 183-8561 2-8-29 Tel.042-300-5111 Fax.042-312-8162 E-mailkoichi_miyata@tmhp.jp 3.
4. / / / NTT 5. 183-8561 2-8-29 Tel.042-300-5111, Fax.042-312-8162 E-mailsn_datacenter09@tmhp.jp 6. 7.
14. 1Makino N, Nakamura Y, Yashiro M, et al: Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. J Epidemiol 25:239-245, 2015 223 http://www.jichi.ac.jp/dph/kawasakibyou/20150924/mcls23report.pdf 3Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94:1379-1385. 4 2012 2013 http://www.j-circ.or.jp/guideline/pdf/jcs2013_ogawas_h.pdf 5Newburger JW, Takahashi M, Gerber MA, et al.diagnosis, treatment, and long-term management of Kawasaki disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747-2071. 6Iemura M, Ishii M, Sugimura T, et al. Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart. 2000;83:307-311. 7Tsuda E, Kamiya T, Kimura K, et al. Coronary artery dilatation exceeding 4.0 mm during acute Kawasaki disease predicts a high probability of subsequent late intima-medial thickening. Pediatr Cardiol. 2002; 23:9-14. 8Manlhiot C, Millar K, Golding F, et al: Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease. Pediatr Cardiol2010;31:242 249 9Fuse S, Kobayashi T, Arakaki Y, et al. Standard method for ultrasound imaging of coronary artery in children. Pediatr Int. 2010;52:876-82. 10Kobayashi Y, Fuse S, Sakamoto N, et al: A New Z-score curve of the coronary arterial internal diameter using the lambda-mu-sigma method in a pediatric population. J Am Soc Echocardiogr. 2016 (in press). 11Ogata S, Tremoulet AH, Sato Yet al. Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. Int J Cardiol. 2013;168:3825 3828. 12Z-Score Project 2nd Stagehttp://raise.umin.jp/zsp2/ 13Onouchi Z, Hamaoka K, Sakata K, et al. Long-term changes in coronary artery aneurysmsin patients with Kawasaki disease - comparison of therapeutic regimens -Circ J 2005;69:265 272. 14Millar K, Manlhiot C, Yeung RS, et al. Corticosteroid administration for patients with coronary artery aneurysms after Kawasaki disease may be associated with impaired regression. Int J Cardiol. 2012;154:9-13. 15Suda K, Kudo Y, Higaki T, et al. Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease. Circ J. 2009;73:1319-1323.
16Suda K, Tahara N, Honda A, et al. Statin reduces persistent coronary arterial inflammation evaluated by serial 18fluorodeoxyglucose positron emission tomography imaging long after Kawasaki disease. Int J Cardiol. 2015;179:61-62. 17Fukazawa R, Sonobe, Hamamoto K, et al. Possible synergic effect of angiotensin-i converting enzyme gene insertion/deletion polymorphism and angiotensin-ii type-1 receptor 1166A/C gene polymorphism on ischemic heart disease in patients with Kawasaki disease. Pediatr Res. 2004;56:597-601. 18McRinlde BW. North American Kawasaki Disease Registry - Advancing clinical research through collaboration. http://circ.ahajournals.org/content/131/suppl_2/a222.abstract 19McRinlde BW, Manlhiot C, Sexson K, et al. Medium-term outcomes of coronary artery aneurysms after Kawasaki disease: A study from the North American Kawasaki Disease Registry. http://circ.ahajournals.org/content/131/suppl_2/ao58 20Ayusawa M, Sonobe T, Uemura S, et al. Kawasaki Disease Research Committee. Revision of diagnostic guidelines for Kawasaki diseasethe 5th revised edition. Pediatr Int. 2005;47232-234. 21American Heart Association. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease: A reporting system on patients evaluated for coronary artery disease. Circulation 1975;5:5-40. 2258 19831-10. http://www.niph.go.jp/wadai/mhlw/1983/s5805004.pdf http://www.niph.go.jp/wadai/mhlw/1984/s5906011.pdf 23Onouchi Z, Shimazu S, Kiyosawa N, et al. Aneurysms of the Coronary Arteries in Kawasaki Disease. An Angiographic Study of 30 Cases. Circulation. 1982;66:6-13. 24Research Committee on Kawasaki Disease. Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Tokyo, Japan: Ministry of Health and Welfare; 1984. 25Eisenberg MJ, Windle SB,Roy N, et al. Varenicline for smoking cessation in hospitalized patients with acute coronary syndrome. Circulation 2016;133:21-30. 26 2011ST 2012. 27 2012ST 2013.4 28Fuse S, Kobayashi T, Arakaki Y, et al. Standard method for ultrasound imaging of coronary artery in children. Pediatr Int. 2010;52:876-882. 29! http://raise.umin.jp/zsp/download/zscore-guide.pdf